We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Akers Bio | LSE:AKR | London | Ordinary Share | COM SHS NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.50 | 50.00 | 65.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/3/2016 11:54 | ww, do you have an answer to the earlier (general) question posed re: For any would be investor here, the first question I would ask them to consider is a very simple one; can you find / obtain a single piece of evidence, after having read the posts on here from #3055, to compel you to place your trust, as a potential shareholder, in Dr Raymond F. Akers Jr., Ph.D.? Appreciate that the reason for our choice of investments may be varied and wide ranging but, assuming that you are "not at arms length", be interested to hear your take on the issue / question. | mcmather | |
02/3/2016 10:58 | "ww is not at arms length"Fact: you are a purveyor of poorly substantiated twaddle. | wigwammer | |
02/3/2016 10:51 | No,Prawn we are not; If you do not know the record, and it is staring you in the face, how dare you talk about poorly substantiated aqccusations when they derive off the published records ? You can put your head in the sand and choke for all I care, Akers stinks and the pattern just repeaats itself and the records do not lie. Bioboy had a chance with TN but he let him go because he could not keep his hands off the money raised for a M&A program Thomas felt the right way to create value. I'd say this is now looking like it was always run on scam lines; The salary Akers pays himself is just robbery; He would not gert a job beyond $40000 if any party would take him on. | norbus | |
02/3/2016 10:08 | It appears you are prone to poorly substantiated accusation.Very bullish indeed.Hope you didn't sell right at the lows. | wigwammer | |
02/3/2016 09:44 | There have been a few down the years Norubus; increases the fun and games I suppose. Can you think of anyone who that might remind of you; ie thinking themselves to be smart and clever but ending up as an untrustworthy laughing stock in the investor community?? | mcmather | |
02/3/2016 09:14 | mcm give up; ww is not at arms length | norbus | |
02/3/2016 08:50 | ww, not a scam per se but certainly a nice, sloshy gravy train if you can get yourself aboard and perhaps get a couple of 'the old boys' along for the ride. In post 3117 (just over 7 hours prior to this 'order' announcement) I commented: Now if you could do enough to generate a bit of shareholder interest, let the results allow those shareholders to cut their losses then promise a bit more jam tomorrow to recruit others and that helps keep you in a manner that you have become accustomed to (eg a remuneration package of $335,000 per year), you may soon find yourself approaching retirement in a healthy position. Post 3119 then alluded to "...revenues are reportedly just $3.09m (FY15)". And just over 7 hours later there is a single 'order valued at approximately' - ie not a definitive contract - and which almost equals last year's revenue... With post 3119 also including: For any would be investor here, the first question I would ask them to consider is a very simple one; can you find / obtain a single piece of evidence, after having read the posts on here from #3055, to compel you to place your trust, as a potential shareholder, in Dr Raymond F. Akers Jr., Ph.D.? | mcmather | |
02/3/2016 08:49 | You pays your money and you takes your choice; good luck, trying to post like a suave investor who is independent; I do not believe you are | norbus | |
02/3/2016 07:54 | Perhaps mm. Though developing and marketing fda approved testing kits is one of the more elaborate scams I've come across. | wigwammer | |
02/3/2016 07:21 | mcm another of the many mirage orders they have had over the years; the tranches, the big number, for the sake of those with hands in this *h1t I wish this is not another mirage | norbus | |
02/3/2016 00:08 | Re the above article and the reference to "AKER holds $5.6m (mrq) in cash", as can be seen in the header and in terms of whether Dr Raymond F. Akers Jr., Ph.D is a man to be trusted or whether he is a simple liar: 11 December 2014 and Dr Raymond Akers has just stated in interview: "We have $10m worth of cash and do not foresee dipping(?) too much in to that cash before we turn cash flow positive"... | mcmather | |
01/3/2016 20:35 | I should add I bought during recent lull. Probably biased! Very illiquid but hope this improves in event things recover. Current 170usd price should translate to around 120p over here, yet current mid price here under a quid. | wigwammer | |
01/3/2016 20:27 | Thanks mm. Agree it doesn't sound like a bed of roses. But the price is telling us that. Every now and then a dog like this bites back. Is there that potential here? The heparin test they are pushing is 90%+ gross margin. They don't have to sell much and the market will get excited about the bottom line impact.Re the new recruit - it takes all sorts to get a business like this going - brains, brawn, people with contacts - the psychology of a successful marketeer is often a Pandora's box. This one is a non exec, so perhaps a more background role, but one with useful contacts. Even assuming a mercenary angle, it is difficult to see why they'd bother if Akers was obviously finished. Seems to be firming a little in the US in recent days so fingers crossed for some long awaited good news. | wigwammer | |
29/2/2016 22:29 | "If the products were effective and competitive, the market would have gobbled them up or the company."Not necessarily. Sometimes it takes time and funding to change practice. I don't concur with the view that all small companies with potential get acquired - because otherwise there wouldn't be successful companies out there that grow and reward holders over time - there evidently are.Perhaps Akers is worth nothing. Or perhaps with a significant funded sales effort they can get some momentum going. Things appeared to be progressing until Q3 - but maybe this is too short a period to assess any change in direction. Will be clearer after next quarterly. There is certainly little built into the price down here. | wigwammer | |
29/2/2016 17:02 | If the products were effective and competitive, the market would have gobbled them up or the company. I used to think they might have been, but nothing seems to offer anything the market wants in any quantity that would ensure the company sustainability | norbus | |
29/2/2016 16:44 | Post 3109. Not sure what this has to do with akers.Are the products no good? Perhaps they just needed a sales team and funds to push them, which they now have. | wigwammer | |
29/2/2016 15:05 | btw share price on nasdaq of US$1.64 = £1.17 approx. A share price on nasdaq of US$1.72 = £1.23 approx. | mcmather | |
29/2/2016 10:24 | "Akers is finished"Is it not odd therefore, that they appear to be attracting some pretty experienced people to join? | wigwammer | |
29/2/2016 09:20 | and draining the bank balance; Akers is finished but the UK fund manager in for the ride, may need to look for something to reverse | norbus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions